AAAAAA

   
Results: 1-25 | 26-34 |
Results: 26-34/34
What is the potential of biotechnology in diagnosis and therapy?
Authors: Oliver, RTD Strefford, JC
Citation: Rtd. Oliver et Jc. Strefford, What is the potential of biotechnology in diagnosis and therapy?, CHALLENGES IN PROSTATE CANCER, 2000, pp. 29-49
The management of residual masses after chemotherapy in metastatic seminoma
Authors: Ravi, R Ong, J Oliver, RTD Badenoch, DF Fowler, CG Hendry, WF
Citation: R. Ravi et al., The management of residual masses after chemotherapy in metastatic seminoma, BJU INT, 83(6), 1999, pp. 649-653
Recent progress in cytokine therapy for renal cell cancer: a case for the European Organization for Research and Treatment of Cancer adjuvant cytokine trial in patients with poor-risk renal cell cancer after maximum debulking surgery
Authors: Ravi, R Oliver, RTD
Citation: R. Ravi et Rtd. Oliver, Recent progress in cytokine therapy for renal cell cancer: a case for the European Organization for Research and Treatment of Cancer adjuvant cytokine trial in patients with poor-risk renal cell cancer after maximum debulking surgery, BJU INT, 83(3), 1999, pp. 219-221
Sixty percent salvage rate for germ-cell tumours using sequential m-BOP, surgery and ifosfamide-based chemotherapy
Authors: Shamash, J Oliver, RTD Ong, J Raja, M Edmonds, P Gallagher, CJ Ostrowski, MJ LeVay, J Williams, M
Citation: J. Shamash et al., Sixty percent salvage rate for germ-cell tumours using sequential m-BOP, surgery and ifosfamide-based chemotherapy, ANN ONCOL, 10(6), 1999, pp. 685-692
Interferon-alpha and survival in metastatic renal carcinoma: early resultsof a randomised controlled trial
Authors: Ritchie, A Griffiths, G Parmar, M Fossa, SD Selby, PJ Cornbleet, MA Sibley, G Mead, GM Kaye, S Owen, JR Oliver, RTD Smith, PH Whelan, P Cook, PA Fayers, PM Cook, P Webb, J Whitehead, J Lamont, A
Citation: A. Ritchie et al., Interferon-alpha and survival in metastatic renal carcinoma: early resultsof a randomised controlled trial, LANCET, 353(9146), 1999, pp. 14-17
Standardization and potential use of HPLC for detection of cellular placental alkaline phosphatase using established tumour cell lines and fresh tumour biopsies
Authors: Torabi-Pour, N Nouri, AME Chineguwndo, F Oliver, RTD
Citation: N. Torabi-pour et al., Standardization and potential use of HPLC for detection of cellular placental alkaline phosphatase using established tumour cell lines and fresh tumour biopsies, UROL INTERN, 63(4), 1999, pp. 234-241
Profile of placental alkaline phosphatase expression in human malignancies: Effect of tumour cell activation on alkaline phosphatase expression
Authors: Dabare, AANPM Nouri, AME Cannell, H Moss, T Nigam, AK Oliver, RTD
Citation: Aanpm. Dabare et al., Profile of placental alkaline phosphatase expression in human malignancies: Effect of tumour cell activation on alkaline phosphatase expression, UROL INTERN, 63(3), 1999, pp. 168-174
A lesson in the management of testicular cancer in a patient with a solitary testis
Authors: Sawyer, EJ Oliver, RTD Tobias, JS Badenoch, DF
Citation: Ej. Sawyer et al., A lesson in the management of testicular cancer in a patient with a solitary testis, POSTG MED J, 75(886), 1999, pp. 481-483
Risk factors for testicular germ cell tumours by histological tumour type
Authors: Coupland, CAC Chilvers, CED Davey, G Pike, MC Oliver, RTD Forman, D
Citation: Cac. Coupland et al., Risk factors for testicular germ cell tumours by histological tumour type, BR J CANC, 80(11), 1999, pp. 1859-1863
Risultati: 1-25 | 26-34 |